Emerging resistance to carbapenems in a tertiary care hospital in north India

Indian Journal of Medical Research

Volumn 124, Issue 1, 2006, Pages 95-98

  Gupta, Ekta ^a   Mohanty, Srujana ^a   Sood, Seema ^a   Dhawan, Benu ^a   Das, Bimal K ^a   Kapil, Arti ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Carbapenems; Gram negative bacilli; Resistance

Indexed keywords

CARBAPENEM DERIVATIVE; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER; CONTROLLED STUDY; DIFFUSION; ENTEROBACTER; ENZYME SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; HOSPITAL; HUMAN; HUMAN TISSUE; INDIA; INTENSIVE CARE UNIT; KLEBSIELLA; NONHUMAN; PROTEUS; PSEUDOMONAS; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 33748121989     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Eisenstein BI, Zaleznik DF. Enterobacteriaceae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and practice of infectious diseases, 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000 p. 2294-310.
2. Livermore DM. β-lactamase mediated resistance and opportunities for its control. J Antimicrob Chemother 1998; 41 (Suppl D) : 25-41.
3. Mathur P, Kapil A, Das B, Dhawan B. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Indian J Med Res 2002; 115 : 153-7.
4. Mohanty S, Kapil A, Das BK, Dhawan B. Antimicrobial resistance profile of nosocomial uropathogens in a tertiary care hospital. Indian J Med Sci 2003; 57: 148-54.
5. Mohanty S, Kapil A, Dhawan B, Das BK. Bacteriological and antimicrobial susceptibility profile of soft tissue infections from Northern India. Indian J Med Sci 2004; 58 : 10-5.
6. Navaneeth BV, Sridaran D, Sahay D, Belwadi MRS. A preliminary study on metallo β-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116 : 264-7.
7. Chitnis SV, Chitnis V, Sharma N, Chitnis DS. Current status of drug resistance among gram-negative bacilli isolated from admitted cases in a tertiary care center. J Assoc Physicians India 2003; 51 : 28-32.
8. Kurokawa H, Yagi T, Shibata N, Shibayana K, Arakawa Y. Worldwide proliferation of carbapenem resistant gram-negative bacteria. Lancet 1999; 354 : 955.
9. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inone M. Plasmid coded metallo β-lactamase (imp-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001; 45 : 1343-8.
10. National Committee for Clinical Laboratory Standards (NCCLS) (2003) Performance standards for antimicrobial disk susceptibility tests, 8th ed. Approved standards. NCCLS Document M2-A8, Wayne PA.
11. Manual on antimicrobial resistance and susceptibility testing. Division of emerging and other communicable diseases surveillance and control. WHO antimicrobial resistance monitoring programme. Geneva: World Health Organization; Sept. 1997.
12. Hancock REW. Resistance mechanisms in Pseudomonas aeruginosa and other non-fermentative gram-negative bacteria. Clin Infect Dis 1998; 27 (Suppl 1) : S 93-9.
13. Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998-2001. Antimicrob Agents Chemother 2003; 47 : 1681-8.
14. Forster DH, Daschner FD. Acinetobacter species as nosocomial pathogens. Eur J Clin Microbiol Infect Dis 1998; 17 : 73-7.
15. Gonlugur U, Bakiri MZ, Akkurt I, Efeoglu T. Antibiotic susceptibility patterns among respiratory isolates of gram-negative bacilli in a Turkish University Hospital. BMC Microbiol 2004; 4 : 32-6.